======= SAV1 ======= == Gene Information == * **Official Symbol**: SAV1 * **Official Name**: salvador family WW domain containing protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=60485|60485]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H4B6|Q9H4B6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SAV1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SAV1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607203|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulator of STK3/MST2 and STK4/MST1 in the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. SAV1 is required for STK3/MST2 and STK4/MST1 activation and promotes cell-cycle exit and terminal differentiation in developing epithelial tissues. Plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with STK3/MST2, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. {ECO:0000269|PubMed:16930133, ECO:0000269|PubMed:19212654, ECO:0000269|PubMed:21076410, ECO:0000269|PubMed:21104395}. |WW| |negative regulation of cardiac muscle cell proliferation| |lung epithelial cell differentiation| |intestinal epithelial cell differentiation| |lung cell differentiation| |negative regulation of cardiac muscle tissue growth| |negative regulation of heart growth| |hippo signaling| |regulation of stem cell population maintenance| |lung epithelium development| |negative regulation of organ growth| |negative regulation of cardiac muscle tissue development| |regulation of cardiac muscle cell proliferation| |ventricular septum morphogenesis| |negative regulation of striated muscle tissue development| |molecular adaptor activity| |negative regulation of muscle organ development| |negative regulation of muscle tissue development| |regulation of cardiac muscle tissue growth| |positive regulation of fat cell differentiation| |regulation of heart growth| |hair follicle development| |ventricular septum development| |skin epidermis development| |cardiac septum morphogenesis| |molting cycle process| |hair cycle process| |regulation of cardiac muscle tissue development| |hair cycle| |molting cycle| |regulation of organ growth| |columnar/cuboidal epithelial cell differentiation| |negative regulation of developmental growth| |cardiac septum development| |regulation of fat cell differentiation| |negative regulation of epithelial cell proliferation| |cardiac chamber morphogenesis| |cardiac ventricle development| |digestive tract development| |regulation of striated muscle tissue development| |regulation of muscle tissue development| |regulation of muscle organ development| |digestive system development| |lung development| |cardiac chamber development| |respiratory tube development| |protein stabilization| |respiratory system development| |negative regulation of growth| |heart morphogenesis| |positive regulation of DNA-binding transcription factor activity| |keratinocyte differentiation| |regulation of protein stability| |epidermal cell differentiation| |regulation of developmental growth| |regulation of epithelial cell proliferation| |skin development| |epidermis development| |regulation of DNA-binding transcription factor activity| |heart development| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |regulation of growth| |negative regulation of cell population proliferation| |epithelial cell differentiation| |positive regulation of cell death| |tube development| |circulatory system development| |apoptotic process| |negative regulation of developmental process| |animal organ morphogenesis| |positive regulation of cell differentiation| |programmed cell death| |identical protein binding| |cell death| |epithelium development| |negative regulation of multicellular organismal process| |positive regulation of developmental process| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of cell population proliferation| |regulation of cell death| |intracellular signal transduction| |tissue development| |positive regulation of molecular function| |regulation of cell differentiation| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14140 * **Expression level (log2 read counts)**: 5.23 {{:chemogenomics:nalm6 dist.png?nolink |}}